Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and EvaluationJean-Christophe Harmange, Roger Zanon, Anthony Polverino et al.|Journal of Medicinal Chemistry|2008Cited by 70
Evaluation of a Series of Naphthamides as Potent, Orally Active Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase InhibitorsMatthew M. Weiss, Roger Zanon, Jean-Christophe Harmange et al.|Journal of Medicinal Chemistry|2008Cited by 34
Dual anti-platelet therapy and dento-alveolar surgery. How do we manage patients on anti-platelet medication?Neil Patel, P. Blacklock, Vinod F. Patel et al.|BDJ|2014Cited by 14